狄诺塞麦怎么买呢？

The FDA approval (denosumab) for the treatment of bone metastases from solid tumors was based on the results of three published pivotal clinical trials. A comprehensive analysis of these three studies showed that compared with zoledronic acid, denosumab (denosumab) prolonged the time to the first adverse bone event (ARE) in patients by 17%, or significantly delayed the median time to the first SRE by 8.2 months (27.6 months vs. 19.4 months). months), denosumab (denosumab) also extended the time from the first episode to the recurrence of SRE by 18% in the study; in addition, for patients with mild or no pain at the time of study enrollment, denosumab (denosumab) also significantly prolonged the time to pain exacerbation compared with zoledronic acid.

How can patients buy denosumab (denosumab)?

Although denosumab (denosumab) has been launched in my country, denosumab (denosumab) has not yet been officially sold in hospitals. Therefore, patients cannot buy this drug domestically. They can only buy it in countries and regions where denosumab (denosumab) is already on the market. It is worth mentioning that the price of Amgen’s original drug denosumab (denosumab) in Turkey is the lowest in the world, and the specification of denosumab in Turkey is 125mg/1ml. Pack/box, the price is equivalent to RMB 3,000.

  If domestic patients want to buy Turkish denosumab (denosumab), they should choose regular drug purchase channels. There are currently many counterfeit drugs in Turkey on the market. The use of counterfeit drugs for treatment not only poses a major hidden danger to the patient's life safety, but also has a low effective concentration of the drug in the counterfeit drugs, which may develop drug resistance and make it difficult to treat the disease even if it is taken with genuine drugs. Therefore, it is recommended that patients get their medicines directly from regular Turkish hospitals. In addition, you can also obtain genuine Turkish-marketed (denosumab) through domestic professional overseas medical service institutions.